Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial

AIMS: Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical variables for the diagnosis of pneumonia in patients presenting to emergency departments (EDs) with a c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maisel, Alan, Neath, Sean-Xavier, Landsberg, Judd, Mueller, Christian, Nowak, Richard M., Peacock, W. Frank, Ponikowski, Piotr, Möckel, Martin, Hogan, Christopher, Wu, Alan H.B., Richards, Mark, Clopton, Paul, Filippatos, Gerasimos S., Di Somma, Salvatore, Anand, Inder, Ng, Leong L., Daniels, Lori B., Christenson, Robert H., Potocki, Mihael, McCord, James, Terracciano, Garret, Hartmann, Oliver, Bergmann, Andreas, Morgenthaler, Nils G., Anker, Stefan D.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Diagnosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284113/
https://ncbi.nlm.nih.gov/pubmed/22302662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hfr177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados